ENTITY
Regulus Therapeutics

Regulus Therapeutics (RGLS US)

1
Analysis
Health CareUnited States
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat and prevent hepatitis C infections, cardiovascular, fibrosis, oncology, immuno-inflammatory, and metabolic diseases. Regulas Therapeutics offers its services worldwide.
more
Company Event22 Mar 2025 04:00 • Upcoming
Add To Calendar
Company Event07 Nov 2024 07:00 • Upcoming
Add To Calendar
Company Event09 Aug 2024 04:00 • Upcoming
Add To Calendar
Company Event24 Jun 2024 20:30 • Latest
Company Event10 May 2024 04:00 • Upcoming
Add To Calendar
x